BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24204026)

  • 1. Targeting microRNAs in pancreatic cancer: microplayers in the big game.
    Khan S; Ansarullah ; Kumar D; Jaggi M; Chauhan SC
    Cancer Res; 2013 Nov; 73(22):6541-7. PubMed ID: 24204026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
    Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
    Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy.
    Passadouro M; Faneca H
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
    Previdi MC; Carotenuto P; Zito D; Pandolfo R; Braconi C
    Future Oncol; 2017 Feb; 13(5):443-453. PubMed ID: 27841659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNAs and lung cancer: tumors and 22-mers.
    Du L; Pertsemlidis A
    Cancer Metastasis Rev; 2010 Mar; 29(1):109-22. PubMed ID: 20130964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in pancreatic ductal adenocarcinoma: new diagnostic and therapeutic clues.
    Seux M; Iovanna J; Dagorn JC; Dusetti NJ
    Pancreatology; 2009; 9(1-2):66-72. PubMed ID: 19077456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma.
    Papaconstantinou IG; Lykoudis PM; Gazouli M; Manta A; Polymeneas G; Voros D
    Pancreas; 2012 Jul; 41(5):671-7. PubMed ID: 22695087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.
    Rachagani S; Kumar S; Batra SK
    Cancer Lett; 2010 Jun; 292(1):8-16. PubMed ID: 20004512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.
    Xia T; Chen XY; Zhang YN
    Mol Cell Biochem; 2021 Dec; 476(12):4191-4203. PubMed ID: 34324119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
    Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
    BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
    Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
    Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer.
    Li Y; Sarkar FH
    Int J Biol Sci; 2016; 12(3):326-37. PubMed ID: 26929739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in Pancreatic Cancer: Advances in Biomarker Discovery and Therapeutic Implications.
    Madadjim R; An T; Cui J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-based Targeted Therapeutics in Pancreatic Cancer.
    Gurbuz N; Ozpolat B
    Anticancer Res; 2019 Feb; 39(2):529-532. PubMed ID: 30711926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA replacement therapy in cancer.
    Mollaei H; Safaralizadeh R; Rostami Z
    J Cell Physiol; 2019 Aug; 234(8):12369-12384. PubMed ID: 30605237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma.
    Li W; Lebrun DG; Li M
    Chin J Cancer; 2011 Aug; 30(8):540-50. PubMed ID: 21801602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in pancreatic ductal adenocarcinoma.
    Park JY; Helm J; Coppola D; Kim D; Malafa M; Kim SJ
    World J Gastroenterol; 2011 Feb; 17(7):817-27. PubMed ID: 21412491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer and microRNAs: therapeutic impact.
    Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
    Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting miRNAs for pancreatic cancer therapy.
    Shi M; Xie D; Gaod Y; Xie K
    Curr Pharm Des; 2014; 20(33):5279-86. PubMed ID: 24479803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.